“biontech” Archives

in
Entry Author Date Location
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More 10/09/20 National
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More 09/18/20 National
Neogene Therapeutics Grabs $110M to Tackle Solid Tumors With Cell Therapy 09/15/20 Europe
Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More 09/11/20 National
Bio Roundup: J&J Buyout, BioMarin Rebuffed, Poseida on Hold & More 08/21/20 National
CureVac’s IPO Hauls In $213M as Key mRNA COVID-19 Vaccine Test Nears 08/14/20 Europe
Moderna, Pfizer Protocols May Make COVID Vaccines Hard to Compare 08/07/20 National
Bio Roundup: Cerevel’s Shell, Thrive’s Rise, Drug Price Drama & More 07/31/20 National
Pfizer, BioNTech Choose Full Spike Protein for Pivotal Vaccine Test 07/28/20 New York
Bio Roundup: Jazz Drug OK’d, Gilead’s Bet, Moderna Patent Decision & More 07/24/20 National
Moderna Publishes Early COVID-19 Vaccine Data, Preps for Phase 3 Test 07/15/20 Boston
Vor Nabs $110M to Spare Healthy Cells From Targeted Cancer Drugs 07/07/20 Boston
BioNTech’s mRNA COVID-19 Vaccine Shows Early Signs of Sparking Immunity 07/01/20 Europe
Moderna Finalizes Plan, Dose for Phase 3 Test of mRNA COVID Vaccine 06/11/20 Boston
Bio Roundup: Acquisitive Alexion, CRISPR on COVID, C. diff Success & More 05/08/20 National
Bio Roundup: Remdesivir Data, Erasca’s $200M, a New FDA Nod & More 05/01/20 National
Biotech Roundup: GSK’s Ante, Shakeup at Sage, Telehealth’s Rise & More 04/10/20 National
Pfizer, BioNTech Say mRNA COVID-19 Vaccine Trials May Start This Month 04/09/20 National
Sanofi Adds mRNA COVID-19 Vaccine Bet Through Translate Bio Alliance 03/27/20 Europe
Bio Roundup: EQRx’s Ambitions, Nektar No Vote, New Frazier Fund & More 01/17/20 National
Cancer Drug Developer BioNTech to Buy Neon Therapeutics in $67M Deal 01/16/20 Boston
Vir Bio’s IPO Brings In $143M for Tests of Hepatitis B Drug and More 10/11/19 San Francisco
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More 09/27/19 National
Neon’s Early Vaccine Study Is a Peek at Immunotherapy’s Third Wave 07/15/19 Boston
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More 07/12/19 National
Bio Roundup: Rare Disease Showdowns, Prices on TV, Dealmania & More 05/10/19 National
Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More 03/15/19 National
15 For ’19: Key Clinical Data to Watch For Next Year (Part 2) 12/18/18 National
Moderna Raises $604M and Nails Down Biotech’s Biggest IPO Ever 12/06/18 Boston
Eyeing $500M, Moderna Outlines Plans for Biotech’s Biggest IPO Ever 11/09/18 Boston
Page 1 of 2 next page »